Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.38
-0.0600-2.46%
Post-market: 2.390.0100+0.42%19:58 EDT
Volume:125.99K
Turnover:304.45K
Market Cap:5.68M
PE:-0.01
High:2.50
Open:2.45
Low:2.36
Close:2.44
Loading ...
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations